[Basal ganglia and movement disorders : Part 1: the parkinsonian spectrum-Neuroradiological patterns and diagnostic considerations].

Improving access to care through transportation and internet use for patients with atypical parkinsonism: A pilot study.

Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.

Multi-model Diffusion MRI Signatures in Atypical Parkinsonian Disorders.

Real-world evaluation of Armstrong's criteria in corticobasal degeneration: Phenotypic overlap and diagnostic challenges.

Automated differentiation of parkinsonian disorders: an ROI-based analysis of subcortical shape and cortical surface features.

Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration.

Localized Iron Deposition and Shape Changes of Cerebellar Dentate in Progressive Supranuclear Palsy Clinical Variants.

Voice and Speech in Atypical Parkinsonian Disorders.

CORTICOBASAL SYNDROME PRESENTING AS A PROGRESSIVE HEMIPARETIC SYNDROME: A CASE REPORT.

Praja1 E3 ubiquitin ligase and the role it plays in neurodegeneration.

White matter hyperintensities in the deep cerebral venous territory differ between subcortical and cortical 4-repeat tauopathies.

MAPT p.V363I mutation in a patient with presenile dementia and late amyotrophic lateral sclerosis.

The Paper-Toss Test: enhancing bedside recognition of corticobasal syndrome.

Progressive supranuclear palsy and corticobasal syndrome: cross-sectional study of palliative care needs.

Functional network collapse in neurodegenerative disease.

Interpeduncular Angle: A Possible Marker to Differentiate Atypical Parkinsonism from Idiopathic Parkinson's Disease.

The genetic landscape of frontotemporal lobar degeneration: investigation of a diagnostic cohort of 2747 probands.

Potential Role of Transferrin and Vascular Cell Adhesion Molecule 1 in Differential Diagnosis Among Patients with Tauopathic Atypical Parkinsonian Syndromes.

Chorea and Levodopa-Induced Dyskinesia in Corticobasal Syndrome: Two Case Reports with Pathological Insights and Literature Review.

Utility of Locus Coeruleus Signal Intensity on High-resolution T1-weighted MR Imaging with Magnetization Transfer for Differentiating Parkinson's Disease from Atypical Parkinsonism.

The Effects of Multimodal Exercise on Sleep Quality and Architecture, Motor Function, Cognition, Fatigue, and Systemic Inflammation in Corticobasal Syndrome: A Case Report.

Discordant cerebrospinal fluid and positron emission tomography amyloid biomarkers in an APP mutation carrier presenting corticobasal syndrome.

Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study.

Expanding the genetic spectrum of corticobasal syndrome: novel CCNF p.M394L variant from a South Asian cohort.

Unraveling the mystery of alien hand syndrome: when your hand has a mind of its own.

A Biomarker-Based Classification of Corticobasal Syndrome.

A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions.

Tracking prodromal Parkinson's disease: a five-year follow-up of the PARCAS cohort.

Neuroanatomical normative modelling in frontotemporal lobar degeneration: higher heterogeneity in the behavioural variant.

Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation.

α-Synuclein seed amplification assay positivity beyond synucleinopathies.

Possible Contribution of Parietal Lobe Dysfunction to Hand-Foot Synkinesis in Corticobasal Syndrome: A Case Report.

Asymmetric Applause Sign in Corticobasal Syndrome: A Case of Clonic Motor Perseveration.

Acoustic Analysis of Apraxia of Speech in a Japanese Patient With Nonfluent/Agrammatic Variant Primary Progressive Aphasia: A Case Study.

A Review of FDG-PET in Progressive Supranuclear Palsy and Corticobasal Syndrome.

Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis.

Scrambler Therapy for the Treatment of Chronic Neuropathic Pain in Atypical Parkinsonian Disorders: A Case Series.

Progressive Supranuclear Palsy-A Global Review.

Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217.

Alzheimer's disease traits in Parkinson's disease without α-synuclein seeding.

Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals.

[Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome].

Serious Illness Conversation in the Care of Atypical Parkinsonian Disorders: A Practical Guide for Neurology Clinicians.

Cortical hyperexcitability in corticobasal syndrome as revealed by giant somatosensory evoked potentials.

Differences in neuropsychological performance across clinical variants of progressive supranuclear palsy.

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.

Progressive Supranuclear Palsy and Corticobasal Syndrome.

Differences in gait apraxia due to reduced regional cerebral blood flow in the supplementary motor area in corticobasal syndrome: a report of two cases.

Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.

Diagnostic utility of tectal plate measures in clinical variants of progressive supranuclear palsy.

Delayed progressive apraxia of speech: A novel clinical entity distinct from primary progressive aphasia - A descriptive case series.

Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome.

Accelerated Intermittent Theta Burst Stimulation Combined with Balance Training Improves Balance in an Individual with Corticobasal Syndrome.

Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population.

Neurological soft signs in neurodegenerative dementias: Results of the DemeNSS study.

Pick's disease presenting as progressive apraxia of speech: Atypical clinical and neuroimaging features in three autopsy-confirmed cases.

Evaluation of disproportionately enlarged subarachnoid-space hydrocephalus in progressive supranuclear palsy.

Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational research.

A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders.

Cognitive Performance in Parkinson's Spectrum Disorders: a comparative study of patients with Parkinson's Disease, Parkinson's Disease Dementia, Dementia With Lewy Bodies, Progressive Supranuclear Palsy, and Corticobasal Syndrome.

Atypical Imaging Findings in Corticobasal Syndrome: A Case Report.

Neurophysiology of Atypical Parkinsonian Syndromes: A Study Group Position Paper.

Computer Vision Technologies in Movement Disorders: A Systematic Review.

Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer's disease and corticobasal syndrome.

Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative Review.

[18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies.

Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes.

Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis.

Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis.

Case report: Behavioral variant FTD confounding a language variant FTD in a case of PSP-CBS.

Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism.

Identical Seeding Characteristics and Cryo-EM Filament Structures in FTLD-Synuclein and Typical Multiple System Atrophy.

Unveiling the enigmatic: Primary progressive apraxia of speech - A case report.

Relationships between hypometabolism and both β-amyloid and tau PET in corticobasal syndrome.

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.

Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies.

A progranulin gene deletion in frontotemporal lobar degeneration with corticobasal syndrome in a TREDEM case report.

Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism.

Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice.

Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism.

Predicting survival rate by plasma biomarkers and clinical variables in syndromes associated with frontotemporal lobar degeneration.

[The experience of diagnosing Alzheimer's disease based on the study of cerebrospinal fluid biomarkers].

Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates.

Diagnosis and Management of Progressive Corticobasal Syndrome.

Cognitive impairment in PSP compared with PD: assessment by clinical subtype and longitudinal change.

Frequency of anti-IgLON5 disease in patients with a typical clinical presentation of progressive supranuclear palsy/corticobasal syndrome.

L266V MAPT Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Syndrome.

Altered cortical network dynamics during observing and preparing action in patients with corticobasal syndrome.

Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases.

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history.

Lexical markers of disordered speech in primary progressive aphasia and 'Parkinson-plus' disorders.

Corticobasal degeneration: An update.

Transdiagnostic Network Localization of Social, Language, and Motor Symptoms in Patients With Frontotemporal Lobar Degeneration.

Caregiver perspectives enable accurate diagnosis of neurodegenerative disease.

An SBM and TBSS Analysis in Early-stage Patients With Alzheimer's Disease, Lewy Body Dementias, and Corticobasal Syndrome.

Japanese longitudinal biomarker study in progressive supranuclear palsy and corticobasal degeneration: Clinical features of the first registered patients and short-term follow-up analysis.

Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival.

The possible connection between neutrophil-to-high-density lipoprotein ratio and cerebral perfusion in clinically established corticobasal syndrome: a pilot study.

MRI-Based Multi-Class Relevance Vector Machine Classification of Neurodegenerative Diseases.

Asymmetry in Atypical Parkinsonian Syndromes-A Review.

Swiss cheese brain presenting as corticobasal syndrome.

Corticobasal Syndrome: Are There Central or Peripheral Triggers?

Frontotemporal Dementia Differential Diagnosis in Clinical Practice: A Single-Center Retrospective Review of Frontal Behavioral Referrals.

Apraxia phenotypes and frontotemporal lobar degeneration.

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.

A case of corticobasal syndrome possibly associated with anti-Yo antibodies.

Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.

Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies.

Clinical characteristics of Japanese patients with corticobasal degeneration.

Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe.

CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders.

Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis.

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement.

Determinants of care partner burden in atypical Parkinsonian syndromes: A retrospective, multi-center analysis.

Unilateral tactile agnosia as an onset symptom of corticobasal syndrome.

Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study.

Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study.

Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis.

Phenotypic and Positron Emission Tomography with [18F]fluordeoxyglucose (FDG PET) differences in corticobasal syndrome: comparison of two cases.

An ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndrome.

Brain perfusion SPECT in dementia: what radiologists should know.

Relationships between PET and blood plasma biomarkers in corticobasal syndrome.

Expanding the Spectrum of GBA1-Associated Neurodegenerative Diseases in an Italian Family.

Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome.

Usefulness of Olfactory Bulb Measurement in 3D-FIESTA in Differentiating Parkinson Disease from Atypical Parkinsonism.

Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers.

Symptomatic Unilateral Carotid Artery Disease: An Uncommon but Reversible Cause of Corticobasal Syndrome.

Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.

The yes-no reversal phenomenon in patients with primary progressive apraxia of speech.

Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome.

Progressive Supranuclear Palsy Syndrome: An Overview.

An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently.

Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.

Differential Synaptic Loss in β-Amyloid Positive Versus β-Amyloid Negative Corticobasal Syndrome.

Localizing apraxia in corticobasal syndrome: a morphometric MRI study.

Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights.

Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study.

Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.

Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech.

Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.

[Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care].

Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease.

Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders.

Evaluation of cerebrospinal fluid alpha-synuclein seed amplification assay in PSP and CBS.

Primary Progressive Apraxia of Speech Caused by TDP-43: A Case Report.

SQSTM1 Pro392Leu presenting as a corticobasal syndrome with progressive nonfluent aphasia.

Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.

Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders.

Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis.

Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome.

Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome.

Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.

Deep vein thrombosis and its risk factors in neurodegenerative diseases: A markedly higher incidence in Parkinson's disease.

Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review.

Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS).

Glucose Metabolism and Cognitive Decline in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Preliminary Study.

Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid.

Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review.

Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS.

Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.

Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.

Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.

Clinical course in corticobasal syndrome and corticobasal degeneration: implications for diagnosis and management.

Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PET.

Neuronal Antibody-Associated Corticobasal Syndrome.

Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome.

The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome.

[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.

Optineurin in patients with Amyotrophic Lateral Sclerosis associated to atypical Parkinsonism in Tunisian population.

Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups.

Lingual and Facial Myoclonus Associated with Early Corticobasal Syndrome.

The Effectiveness of Transcranial Magnetic Stimulation in Treating Apraxia.

Pick's disease presenting with corticobasal syndrome: A case report and clinicopathological review.

Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.

Grey-matter correlates of empathy in 4-Repeat Tauopathies.

Atypical findings: Atypical parkinsonian syndromes or Atypical parkinsonian syndromes look-alikes.

Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome.

Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study.

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.

Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome.

A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease.

[Autoimmune encephalitis and paraneoplastic neurological syndromes presenting atypical parkinsonism: a scoping review].

A non-invasive method for prediction of neurodegenerative diseases using gait signal features.

High sensitivity of asymmetric 18F-THK5351 PET abnormality in patients with corticobasal syndrome.

Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum.

[18F]-FDopa positron emission tomography imaging in corticobasal syndrome.

Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum.

Detection of episodic nocturnal hypercapnia in patients with neurodegenerative disorders.

Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.

Multiclass characterization of frontotemporal dementia variants via multimodal brain network computational inference.

Large-scale activation likelihood estimation meta-analysis of parkinsonian disorders.

Apraxia of Speech in the Spontaneous Speech of Nonfluent/Agrammatic Primary Progressive Aphasia.